| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/23/2005 | CN1584029A Long-noded pit viper poison dissolving fiber protein No.2 gene and use thereof |
| 02/23/2005 | CN1583793A Human alpha 1-thymic peptide composition and its preparation |
| 02/23/2005 | CN1583791A Extraction and purification of sheep skin growth factor as medicine for inflammatory enteropathy |
| 02/23/2005 | CN1583790A Extracting method for pork liver metal sulfur protein |
| 02/23/2005 | CN1583789A Soybean transcripting factor, its coding gene and use thereof |
| 02/23/2005 | CN1583788A Tanscription activating factor genes of candida albicans and their use |
| 02/23/2005 | CN1583787A Stimulated polypeptide, its coding genes and use of capsule protein HVR1 of hepatitis C virus |
| 02/23/2005 | CN1583786A Polypeptide and use thereof |
| 02/23/2005 | CN1582771A Production of collagen peptide from fish skins |
| 02/23/2005 | CN1190493C Preparation method of reversible photochromic biliprotein |
| 02/23/2005 | CN1190492C Cotton Na+/H+ reverse transport protein gene and its cloning method and application |
| 02/23/2005 | CN1190491C PRV-gene and use thereof |
| 02/23/2005 | CN1190490C Isolation and charaterization of fiber-specific beta-tubulin promoter from cotton |
| 02/23/2005 | CN1190447C Human hyaloid band B cell epitose fusogenic peptide and its production process |
| 02/23/2005 | CN1190446C New human protein with function of improving mouse NIH/3T3 cell transformation and its encoding sequence |
| 02/23/2005 | CN1190445C Process for producing functional silk fibroin and utilization of the same |
| 02/23/2005 | CN1190234C Technology for industrially preparing spirulina polynutrient |
| 02/22/2005 | US6858778 Plants transformed with a DNA construct comprising a nucleic acid molecule encoding an 18 kD α-globulin |
| 02/22/2005 | US6858776 Plants having modified reproductive capacity |
| 02/22/2005 | US6858775 Method for generating split, non-transferable genes that are able to express an active protein product |
| 02/22/2005 | US6858774 Nucleotide sequences coding polypeptides for use in bioremediation and detoxification |
| 02/22/2005 | US6858772 Transgenic mice containing magnesium-dependent protein phosphatase gene disruptions |
| 02/22/2005 | US6858712 Cloning and expression of HTLV-III DNA |
| 02/22/2005 | US6858710 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 02/22/2005 | US6858709 Component of von Hippel-Lindau tumor suppressor complex and SCF ubiquitin ligase |
| 02/22/2005 | US6858707 Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response |
| 02/22/2005 | US6858706 Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| 02/22/2005 | US6858704 Oligopeptide sequences with c-terminal acidic tails (ATS); increased stability in enzymes, foods, medicines and chemical products |
| 02/22/2005 | US6858590 With an antigen that has an epitope of hepatitis c virus |
| 02/22/2005 | US6858586 Pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation |
| 02/22/2005 | US6858583 For regulating the abnormal stem cell cycle and for accelerating the post-chemotherapy peripheral blood cell recovery |
| 02/22/2005 | US6858579 Comprising the amino acid sequence AMVSE and not EQEYVQTV; for inhibiting leukocyte migration and diseases such as gout, arthritis, asthma, reperfusion injury |
| 02/22/2005 | US6858578 Chimeric proteins for use in transport of a selected substance into cells |
| 02/22/2005 | US6858576 Methods for regulating gastrointestinal motility |
| 02/22/2005 | US6858438 Peptides immunoreactive with autoantibodies from patients with rheumatoid arthritis |
| 02/22/2005 | US6858431 An osteoinductive soluble factor induced by the expression of human mineralization protein. |
| 02/22/2005 | US6858426 Grapevine leafroll virus (type 2) proteins and their uses |
| 02/22/2005 | US6858410 Process for making antifusogenic fusion peptides that form inclusion bodies |
| 02/22/2005 | US6858409 Identifying nucleotide sequences which code modulator for treating arthritis, inflammatory bowel, sepsis and adult respiratory distress diseases; immunosuppressant |
| 02/22/2005 | US6858407 Nucleotide sequences coding polypetide for use in the treatment, prevention and diagnosis of gastrointestinal and apoptosis disorders |
| 02/22/2005 | US6858406 Process for the microbial production of amino acids by boosted activity of export carriers |
| 02/22/2005 | US6858404 Genes for the biosynthesis of epothilones |
| 02/22/2005 | US6858395 Diagnoss and treatment of muscular disorders; obtain tissue sample, detect preferential gene expression, amplified transcription of prferential gene indicates muscular disorder |
| 02/22/2005 | US6858389 Growth hormone-regulatable liver genes and proteins, and uses thereof |
| 02/22/2005 | US6858385 Pseudorabies virus protein |
| 02/22/2005 | US6858383 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| 02/22/2005 | US6858382 Detection systems for registering protein interactions and functional relationships |
| 02/22/2005 | US6858234 Extracting enzyme inhibitors from wheat flour or gluten for treating hyperglycemia, diabetes, hyperlipemia and arteriosclerosis |
| 02/22/2005 | US6858210 For inducing tolerance in an individual; bind to anti-cardiolipin ( beta 2GPI-dependent antiphospholipid) |
| 02/22/2005 | US6858208 Increased muscle tissue; transgenic animal |
| 02/22/2005 | US6858207 Methods and materials relating to novel CD39-like polypeptides |
| 02/22/2005 | US6858204 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/22/2005 | CA2271232C Modified protein c and methods of use thereof |
| 02/22/2005 | CA2185352C Novel muteins of ifn-.beta. |
| 02/22/2005 | CA2093022C Targeted immunostimulation with bispecific reagents |
| 02/17/2005 | WO2005015206A2 Secreted polypeptide species associated with cardiovascular disorders |
| 02/17/2005 | WO2005015154A2 Autocatalysis/yeast two-hybrid assay |
| 02/17/2005 | WO2005014863A1 Mutations in ion channels |
| 02/17/2005 | WO2005014838A1 Chimeric antigens for breaking host tolerance to foreign antigens |
| 02/17/2005 | WO2005014836A2 Chimaeric vector system |
| 02/17/2005 | WO2005014835A1 Use of fak-related non-kinase in the manufacture of a medicament for the inhibition of stenosis and restenosis |
| 02/17/2005 | WO2005014828A2 Process for the production of fine chemicals in plants |
| 02/17/2005 | WO2005014826A1 Use of npabc1 transporter and promoter thereof |
| 02/17/2005 | WO2005014825A2 Methods of protein production in yeast |
| 02/17/2005 | WO2005014823A2 Targeted carrier fusions for delivery of chemotherapeutic agents |
| 02/17/2005 | WO2005014822A2 Novel therapeutic fusion proteins |
| 02/17/2005 | WO2005014819A1 Esophageal cancer antigen and utilization thereof |
| 02/17/2005 | WO2005014818A1 Gene overexpressed in cancer |
| 02/17/2005 | WO2005014817A2 Chordin-like homologs |
| 02/17/2005 | WO2005014816A1 Antigens for immunocontraception |
| 02/17/2005 | WO2005014813A1 Novel protein usable in screening drug for improving type 2 diabetes |
| 02/17/2005 | WO2005014809A1 Polypeptide specific to liver cancer, polynucleotide encoding the polypeptide and rna molecule inhibiting the expression of the polypeptide |
| 02/17/2005 | WO2005014803A1 West nile virus vaccine |
| 02/17/2005 | WO2005014798A2 Novel compositions and methods for promoting, inhibiting, and detecting protein entry into cells |
| 02/17/2005 | WO2005014792A2 Preservation of biomaterials with transported preservation agents |
| 02/17/2005 | WO2005014791A2 Methods and compositions for targeted cleavage and recombination |
| 02/17/2005 | WO2005014787A2 Genetic elements conferring flower petal-specific transgene expression |
| 02/17/2005 | WO2005014780A2 Prostate stem cell antigen (psca) variants and subsequences thereof |
| 02/17/2005 | WO2005014778A2 Dna vaccine expressing ha1 of equine-2 influenza virus |
| 02/17/2005 | WO2005014654A2 Product comprising a c4bp core protein and a monomeric antigen, and its use |
| 02/17/2005 | WO2005014650A2 Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 02/17/2005 | WO2005014648A1 Process for preparing an alpha-1-antitrypsin solution |
| 02/17/2005 | WO2005014647A1 Product and composition containing a concholepas concholepas hemocyanin (cch) subunit a, and a method of use thereof |
| 02/17/2005 | WO2005014646A1 Method for producing a polypeptide |
| 02/17/2005 | WO2005014645A2 Pedf-r receptor and uses |
| 02/17/2005 | WO2005014644A1 Gene expressed in breast cancer and methods of use |
| 02/17/2005 | WO2005014643A2 Il-11 muteins |
| 02/17/2005 | WO2005014642A2 Novel multifunctional cytokines |
| 02/17/2005 | WO2005014641A2 Ciliary neurotrophic factor variants |
| 02/17/2005 | WO2005014640A1 Method of peptide synthesis |
| 02/17/2005 | WO2005014639A2 Periodic antimicrobial peptides |
| 02/17/2005 | WO2005014638A2 Novel peptide interacting with anti-apoptotic proteins of a bcl-2 family |
| 02/17/2005 | WO2005014637A1 Apoptosis inhibitors |
| 02/17/2005 | WO2005014636A1 Genetically encoded bioindicators of calcium-ions |
| 02/17/2005 | WO2005014635A2 Secreted polypeptide species reduced in cardiovascular disorders |
| 02/17/2005 | WO2005014634A1 A gene and uses therefor |
| 02/17/2005 | WO2005014633A1 Fluorescent protein |
| 02/17/2005 | WO2005014632A1 METHOD FOR OBTAINING AGENTS AGAINST INSECTS BY USING THE STRUCTURAL COORDINATES OF ZADGrau |
| 02/17/2005 | WO2005014631A1 Fungus resistant plants and their uses |
| 02/17/2005 | WO2005014630A2 Streptococcus pneumoniae knockout mutants |